| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $204.3M | +10.5% |
| SG&A Expense | $56.6M | +13.4% |
| Operating Income | -$228.7M | -2.5% |
| Pre-tax Income | -$198.4M | +0.7% |
| Income Tax | $349K | +26.9% |
| Net Income | -$198.7M | +0.7% |
| EPS (Basic) | -$2.35 | +24.7% |
| EPS (Diluted) | -$2.35 | +24.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $172.6M | -16.3% |
| Short-term Investments | $351.7M | -15.8% |
| Current Assets | $542.8M | -14.9% |
| Total Assets | $647.4M | -14.0% |
| Current Liabilities | $42.9M | +16.0% |
| Total Liabilities | $154.0M | +0.5% |
| Stockholders' Equity | $493.4M | -17.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$157.7M | -5.4% |
| Capital Expenditures | $3.7M | -59.8% |
| Investing Cash Flow | $74.9M | +170.4% |
| Financing Cash Flow | $49.2M | -76.9% |
| Free Cash Flow | -$161.4M | -1.6% |